Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB319

Introduced
1/29/25  

Caption

Cattle Fever Tick Eradication Program Enhancement Act of 2025This bill requires the Department of Agriculture (USDA) to enter into a contract to evaluate the Cattle Fever Tick Eradication Program.Under the program, the Animal and Plant Health Inspection Service works in coordination with the Texas Animal Health Commission to combat the spread of cattle fever ticks, which can spread a serious cattle disease called bovine babesiosis or cattle fever.Specifically, USDA must enter into a contract to review and report on the Cattle Fever Tick Eradication Program with a (1) land-grant college or university, or (2) non-land-grant college of agriculture.The review must include an evaluation of the program's (1) effectiveness with respect to preventing and reducing the spread of cattle fever ticks; and (2) benefits, and the burdens of compliance, to cattle producers.The review must also evaluate the treatment protocols developed and implemented under the program.Further, the review must evaluate the federal and state funds allocated to support the program for the most recent fiscal year. 

Impact

The bill seeks to enhance federal and state efforts in addressing cattle fever tick infestations, which could affect livestock health and agricultural economics. By calling for a comprehensive review, the legislation aims to streamline practices and improve efficacy in managing cattle fever ticks. This initiative is significant for cattle producers who may face various challenges and costs associated with compliance under the current program.

Summary

Senate Bill 319, titled the 'Cattle Fever Tick Eradication Program Enhancement Act of 2025', aims to improve the Cattle Fever Tick Eradication Program. This bill directs the Secretary of Agriculture to review the existing program by contracting with covered institutions, such as land-grant universities, to evaluate its effectiveness and compliance burdens on cattle producers. The review is mandated to be conducted within a year of the bill's enactment, focusing on aspects like prevention of cattle fever tick spread and the benefits versus compliance burdens faced by producers.

Contention

While the text does not specify opposition, typical points of contention around agricultural programs like this may revolve around the financial implications for producers, especially regarding any potential increase in regulatory burdens. Stakeholders might also debate the adequacy of current measures against cattle fever ticks and whether additional regulations could impact farmers' operations. By promising to assess compliance hurdles, the bill attempts to address these concerns proactively and seeks to mitigate any adverse effects on cattle producers.

Congress_id

119-S-319

Policy_area

Agriculture and Food

Introduced_date

2025-01-29

Companion Bills

No companion bills found.

Previously Filed As

US HB2420

Cattle Fever Tick Eradication Program Enhancement Act

US SB1836

Cattle Fever Tick Eradication Program Enhancement Act of 2023

US HB3448

American Battlefield Protection Program Enhancement Act of 2023

US SB228

Cattle Price Discovery and Transparency Act of 2023

US HB1287

Cattle Price Discovery and Transparency Act of 2023

US HB10162

RESERVE Federal Land Act Review and Evaluation of Strategies for Equitable Reservations for Visitor Experiences Federal Land Act

US SB3568

American Battlefield Protection Program Enhancement Act of 2024

US HB397

Government Office Realignment And Closure Act of 2023 or the GORAC Act This bill directs the Government Accountability Office (GAO) to provide for an independent evaluation of federal agencies and programs to identify duplicative, wasteful, or outdated functions and provides for congressional consideration of legislation to implement recommendations from the evaluation. Specifically, the GAO must (1) procure the services of a nonfederal auditor to evaluate each federal program carried out in the previous 20 years, make recommendations on federal agencies and programs that should be realigned or eliminated, and report on such recommendations; and (2) take steps to assure that any work performed by such auditor complies with standards established by the GAO for audits of federal establishments, programs, activities, and functions. The GAO must provide for the relocation of federal employees whose positions are eliminated as a result of the implementation of recommendations included in the report.

US HB323

People-Centered Assistance Reform Effort Act or the People CARE Act This bill establishes the People-Centered Assistance Reform Effort Commission within the legislative branch to review federal means-tested welfare programs. Means-tested welfare programs are those designed to specifically provide assistance exclusively to low-income Americans. The commission shall review all federal means-tested programs, excluding various specified programs such as the Social Security benefits program, Medicare, and Department of Veterans Affairs-administered programs. The commission's review shall cover topics including (1) ways to make the benefits programs more efficient and streamlined, (2) opportunities to reduce costs by contracting with private entities or delegating to states, (3) any programs that should be subject to discretionary appropriations, and (4) changes to allow caseworkers to have a holistic view of the beneficiary. The commission shall report its findings to Congress, and the report shall include proposed legislation to carry out the commission's recommendations. The Speaker of the House of Representatives and the Senate majority leader shall introduce the proposed legislation in their respective chambers. The proposed legislation shall be considered under certain expedited procedures, such as limitations on debate.

US HB405

Essential Medicines Strategic Stockpile Act of 2023 This bill requires the Department of Health and Human Services (HHS) to create a pilot program to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage. To carry out the pilot program, HHS must enter into contracts for a term of up to three years with drug manufacturers, co-op or chain pharmacy warehouses, or other eligible entities to create a six-month stockpile of up to 50 types of such drugs. The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.

Similar Bills

No similar bills found.